Strategic Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$769K Buy
8,875
+5,303
+148% +$508K 0.05% 174
2025
Q4
$343K Sell
3,572
-2
-0.1% -$194 0.03% 200
2025
Q3
$340K Sell
3,574
-184
-5% -$16.9K 0.03% 204
2025
Q2
$328K Sell
3,758
-14
-0.4% -$1.19K 0.03% 200
2025
Q1
$339K Buy
3,772
+40
+1% +$3.58K 0.04% 199
2024
Q4
$298K Buy
3,732
+8
+0.2% +$693 0.03% 207
2024
Q3
$335K Sell
3,724
-30
-0.8% -$2.52K 0.04% 209
2024
Q2
$295K Buy
3,754
+55
+1% +$4.51K 0.04% 211
2024
Q1
$322K Buy
3,699
+404
+12% +$34.5K 0.04% 208
2023
Q4
$271K Sell
3,295
-338
-9% -$25.8K 0.04% 210
2023
Q3
$285K Buy
3,633
+163
+5% +$13.6K 0.05% 206
2023
Q2
$306K Buy
3,470
+439
+14% +$37.8K 0.04% 165
2023
Q1
$244K Buy
+3,031
New +$247K 0.04% 218

Other funds holding MDT

Strategic Investment Advisors's MDT Position: Q1 2026 in Review

Strategic Investment Advisors increased its Medtronic (MDT) stake by 148% in Q1 2026, buying an estimated $508K and bringing the position to 8,875 shares worth $769K. The position accounts for 0.05% of the portfolio, ranked #174.

Strategic Investment Advisors first reported a position in MDT in Q1 2023 and has held it in 13 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Strategic Investment Advisors held 8,875 shares of Medtronic worth $769K as of Q1 2026.
  • Strategic Investment Advisors bought 5,303 Medtronic shares in Q1 2026, an estimated $508K.
  • Medtronic made up 0.05% of Strategic Investment Advisors's portfolio in Q1 2026, its #174 holding.
  • Strategic Investment Advisors first reported a position in Medtronic in Q1 2023 and has held it in 13 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Strategic Investment Advisors's 13F filing for Q1 2026, filed 18 May 2026.